Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:03 pm Purchase | 2023-12-31 | 13G | Molecular Templates, Inc. MTEM | Lytton, Laurence W. | 232,951 4.300% | 232,951 (New Position) | Filing History |
| 2024-02-14 1:59 pm Sale | 2023-12-31 | 13G | Miromatrix Medical Inc. MIRO | Lytton, Laurence W. | 0 0.000% | -1,380,367 (Position Closed) | Filing History |
| 2024-02-14 1:49 pm Purchase | 2023-12-31 | 13G | LiqTech International, Inc. LIQT | Lytton, Laurence W. | 589,653 9.990% | 589,653 (New Position) | Filing History |
| 2024-02-14 1:43 pm Sale | 2023-12-31 | 13G | aTyr Pharma, Inc. ATYR | Lytton, Laurence W. | 585,013 1.000% | -3,855,175 (-86.82%) | Filing History |
| 2024-02-14 1:36 pm Purchase | 2023-12-31 | 13G | Giga-tronics Incorporated GIGA | Lytton, Laurence W. | 608,177 9.990% | 4,477 (+0.74%) | Filing History |
| 2024-02-14 1:31 pm Purchase | 2023-12-31 | 13G | EMCORE Corporation EMKR | Lytton, Laurence W. | 778,733 9.990% | 486,406 (+166.39%) | Filing History |
| 2024-02-14 1:23 pm Sale | 2023-12-31 | 13G | Duos Technologies Group, Inc. DUOT | Lytton, Laurence W. | 482,976 6.700% | -151,049 (-23.82%) | Filing History |
| 2024-02-14 1:18 pm Unchanged | 2023-12-31 | 13G | Gyre Therapeutics, Inc. GYRE | Lytton, Laurence W. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 1:10 pm Purchase | 2023-12-31 | 13G | BIOLASE INC PAR $.001 BIOLQ | Lytton, Laurence W. | 26,824 0.600% | 26,824 (New Position) | Filing History |
| 2024-02-14 1:05 pm Sale | 2023-12-31 | 13G | Alimera Sciences, Inc. ALIM | Lytton, Laurence W. | 2,185,364 4.200% | -799,439 (-26.78%) | Filing History |
| 2024-01-11 1:04 pm Purchase | 2023-12-28 | 13G | NeuroOne Medical Technologies Corporation NMTC | Lytton, Laurence W. | 1,304,102 5.200% | 1,304,102 (New Position) | Filing History |
| 2023-12-07 5:15 pm Purchase | 2023-10-25 | 13G | Cellectar Biosciences, Inc. CLRB | Lytton, Laurence W. | 62,836 9.990% | 62,836 (New Position) | Filing History |
| 2023-08-31 11:59 am Purchase | 2023-08-24 | 13G | Societal CDMO, Inc. SCTL | Lytton, Laurence W. | 6,493,690 5.800% | 5,514,741 (+563.33%) | Filing History |
| 2023-08-14 12:20 pm Purchase | 2023-08-02 | 13G | Alimera Sciences, Inc. ALIM | Lytton, Laurence W. | 2,984,803 5.700% | 2,984,803 (New Position) | Filing History |
| 2023-07-20 5:09 pm Purchase | 2023-07-13 | 13G | Molecular Templates, Inc. MTEM | Lytton, Laurence W. | 276,157 5.100% | 276,157 (New Position) | Filing History |
| 2023-05-30 12:11 pm Purchase | 2023-04-20 | 13G | Stryve Foods, Inc. SNAX | Lytton, Laurence W. | 191,501 9.990% | 191,501 (New Position) | Filing History |
| 2023-05-22 4:13 pm Purchase | 2023-05-11 | 13G | Rail Vision Ltd. RVSN | Lytton, Laurence W. | 197,500 7.900% | 197,500 (New Position) | Filing History |
| 2023-05-11 5:06 pm Purchase | 2023-05-02 | 13G | Miromatrix Medical Inc. MIRO | Lytton, Laurence W. | 1,380,367 5.100% | 1,380,367 (New Position) | Filing History |
| 2023-03-07 5:22 pm Sale | 2022-12-31 | 13G | Scientific Industries, Inc. SCND | Lytton, Laurence W. | 394,679 5.500% | -195,529 (-33.13%) | Filing History |
| 2023-02-22 1:40 pm Purchase | 2023-02-09 | 13G | aTyr Pharma, Inc. ATYR | Lytton, Laurence W. | 4,440,188 8.700% | 4,440,188 (New Position) | Filing History |